Clobazam Oral Suspension 5mg/5ml Malta - englanti - Medicines Authority

clobazam oral suspension 5mg/5ml

atnahs pharma uk limited - clobazam - oral suspension - clobazam 5 mg/5ml - psycholeptics

Clobazam Oral Suspension 10mg/5ml Malta - englanti - Medicines Authority

clobazam oral suspension 10mg/5ml

atnahs pharma uk limited - clobazam - oral suspension - clobazam 10 mg/5ml - psycholeptics

Clobazam Micro Labs 10 mg Tabletten Saksa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

clobazam micro labs 10 mg tabletten

micro labs gmbh (8144276) - clobazam - tablette - 10 mg - teil 1 - tablette; clobazam (12632) 10 milligramm

Clobazam Micro Labs 20 mg Tabletten Saksa - saksa - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

clobazam micro labs 20 mg tabletten

micro labs gmbh (8144276) - clobazam - tablette - 20 mg - teil 1 - tablette; clobazam (12632) 20 milligramm

Perizam 1mg/ml Oral Suspension Irlanti - englanti - HPRA (Health Products Regulatory Authority)

perizam 1mg/ml oral suspension

rosemont pharmaceuticals ltd - clobazam - oral suspension - 1 milligram(s)/millilitre - benzodiazepine derivatives; clobazam - anxiolytics - it is indicated in adults for the short-term symptomatic treatment (2-4 weeks) only of anxiety that is severe, disabling or subjecting the individual to unacceptable distress. in treatment of anxiety states associated with affected disorders, perizam must only be used in conjunction with adequate treatments for the underlying disorder. in patients with schizophrenic or other psychotic illnesses, use of benzodiazepines is recommended only for short term symptomatic management of hyperarousal and agitation. benzodiazepines do not possess antipsychotic properties. perizam may be used as adjunctive therapy in epilepsy in adults or children over 6, if standard treatment with one or more anticonvulsants has failed.